NPS Pharmaceuticals Inc. (NASDAQ:NPSP) stock jumped $6.47 (25%) to $32.24 on Wednesday after FDA reviewers concluded that once-daily subcutaneous injections of Natpara reduced the need for calcium and vitamin
Read the full 293 word article
User Sign In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury